In our research, we found a puzzling phenomenon: serum β2M levels were associated with mRS scores, but they were not associated with the NIHSS scores or infarct volumes of AIS patients at admission, which seems paradoxical. This evidence concerns the gene B2M and androgen insensitivity syndrome.